SARS-COV2 INFECTION
Clinical trials for SARS-COV2 INFECTION explained in plain language.
Never miss a new study
Get alerted when new SARS-COV2 INFECTION trials appear
Sign up with your email to follow new studies for SARS-COV2 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single infusion of COVID-Fighting antibodies keep High-Risk patients out of the hospital?
Disease control TerminatedThis study tests whether a single infusion of hyperimmune immunoglobulin (hIVIG) — concentrated antibodies from recovered COVID-19 patients — can help adults at high risk (age 55+ or with weakened immune systems) who have early COVID-19. Participants receive either the antibody i…
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 02, 2026 01:00 UTC
-
Paxlovid tested as a shield against long COVID in 2,000-Person trial
Prevention OngoingThis phase 3 trial tests whether taking Paxlovid (nirmatrelvir/ritonavir) during acute COVID-19 can prevent long COVID. About 2,000 adults aged 18-64 with a recent positive test and symptoms will receive either Paxlovid or a placebo for 5 days. Researchers will track long COVID s…
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE3 • Sponsor: Haukeland University Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Could 'Zombie Cells' be behind long COVID? new study aims to find out
Knowledge-focused OngoingThis study examines whether senescent cells—sometimes called 'zombie cells' that accumulate with age—contribute to Long-Hauler Syndrome, a condition where COVID-19 symptoms persist long after the initial infection. Researchers at Mayo Clinic will compare markers of cellular aging…
Matched conditions: SARS-COV2 INFECTION
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC